Immunomodulators Flop for COVID-19 Pneumonia Outcomes
Immunomodulators abatacept (Orencia), cenicriviroc, and infliximab (Remicade)…
Browsing Tag
immunomodulators
Immunomodulators Global Market Likely to Exhibit Substantial Growth at a CAGR of ~5%…
New York, USA, June 19, 2023 (GLOBE NEWSWIRE) -- Immunomodulators Global Market Likely to Exhibit Substantial Growth at a CAGR of ~5% by 2028 | DelveInsight The immunomodulators…
Immunomodulators Market Size worth US$ 304.37 billion by 2030 to grow at a CAGR of…
Pune, Nov. 16, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Immunomodulators Market will clock US$ 304.37 billion by 2030. The…
Anti-TNF Maintenance Holds Up in IBD, Without Immunomodulators
Inflammatory bowel disease (IBD) patients on maintenance therapy with a tumor necrosis factor…
ADC Combined With Immunomodulators Active in R/R Myeloma
Indatuximab ravtansine (BT062) combined with immunomodulatory drugs showed antitumor activity…
BioAegis Therapeutics Announces Publication of a Compassionate Use Case Study of a…
Gelsolin immunomodulator treatment associated with patient’s rapid recovery. NORTH BRUNSWICK, N.J., Aug. 27, 2021 (GLOBE NEWSWIRE) -- BioAegis Therapeutics Inc., a clinical stage,…